ARCHIVES

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

NIH Advisors Suggest Revamping Grant Application Review

June 14, 1996

Benefit Seen In Novel Drug That Treats Gleevec Resistance

April 29, 2005

New Agency To Evaluate PDQ; NCAB Approves NCI Payment Of Part

June 1, 1990

Lung Cancer Deaths Level Off In White Men, NCI Study Says

January 3, 1992

NCI Picks 11 Centers For Chemical Biology Consortium

October 23, 2009

R.S.K. Young Quits As FDA Oncology Group Leader

July 11, 1980